THE ULTIMATE GUIDE TO SB-674042

quinupristin/dalfopristin will enhance the level or impact of ivacaftor by impacting hepatic/intestinal enzyme CYP3A4 metabolism.quinupristin/dalfopristin will enhance the level or result of lumateperone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Lessen lumateperone dose to 21 mg/working day if coadm